We are happy to announce an opportunity for a 6-months placement between The Vaccine Centre at the London School of Hygiene and Pfizer, funded by the IMPRINT network and based in the UK.
Applicants should be UK-resident academic investigators or academic trainees with a keen interest in Vaccinology, in particular relating to the use of vaccines in pregnancy.
Salary costs and some travel allowance would be available from IMPRINT network funds.
A tri-partite agreement between the applicants home institution, LSHTM and Pfizer would be implemented and the successful applicant “seconded” from his/her home institution with agreement of their respective deanery, where applicable. This opportunity might suit advanced academic trainees in infection and immunity or public health, seeking out of program experience and industry insights.
The scope of work would centre on the development of a framework for a post-approval study to establish the effectiveness of a Group B Streptococcus (GBS) vaccine in prevention of neonatal disease in Lower and Middle Income Countries (LMIC).
The candidate would gain experience in Pfizer policies and procedures on planning and conduct of clinical vaccine trials-in general and not specifically to GBS- through direct interactions and shadowing of Pfizer staff, based in the UK in Hurley, SL6 6RJ.
The position is available as soon as possible but needs to be taken up latest by March 2020.
Please send a CV incl. current salary range and a letter of motivation to IMPRINT@linq-management.com
Deadline for applications: July 31st 2019
Dr Chris Gale from Imperial College London provided new insights about the impact of COVID-19 on the health of neonates in a webinar organised by IMPRINT.